Company news
公司新闻

祁连国际在渝签订生猪副产品加工项目投资协议

文章来源:本站 更新时间:2021-07-09 浏览次数:475

Qilian International Holding Group Limited Enters into Investment Agreement for Pig By-product Processing Project in Chongqing

 

祁连国际在渝签订生猪副产品加工项目投资协议

 

GlobeNewswire 07-09 20:00

 

Jiuquan, China, July 09, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (Nasdaq: QLI) (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company, through its PRC subsidiary Chengdu Qilianshan Biotechnology Co., Ltd., has entered into an investment agreement (the "Agreement") with Chongqing Jin Tong Industrial Construction Investment Co. Ltd. (“CJT”) on July 5, 2021, for the construction of a pig by-product processing facility (the “Project”) in Chongqing.

中国酒泉,2021年7月9日(环球新闻)--总部位于中国的医药及化工产品制造商祁连国际有限公司(纳斯达克:QLI)(“本公司”)今日宣布,本公司通过其中国附属公司成都祁连山生物科技有限公司,已于2021年7月5日与重庆金通工业建设投资有限公司(“CJT”)订立投资协议(“协议”),在重庆建设一个猪副产品加工设施(“项目”)。

The Project is designed to cover an area of about 50 mu (approximately 8.24 acres), with a total investment of RMB540 million (approximately USD83.6 million) and is expected to reach a target annual production capacity of 10 tons of heparin sodium preparations within three years, the value of which being more than RMB500 million (approximately USD77.4 million). The Project is expected to receive preferential policies from the government at the national, municipal and local levels.

该项目规划占地面积约50亩(约8.24英亩),总投资人民币5.4亿元(约83.6百万美元),预计三年内达到肝素钠制剂10吨的目标年生产能力,价值超过人民币5亿元(约7740万美元)。该项目有望获得国家、市、地方各级政府的优惠政策。

Mr. Zhanchang Xin, Chairman and CEO of the Company, commented, “We are very pleased to work with CJT on the Project. As a key area for pig breeding and pork production in China, Chongqing has sufficient raw materials for the production of heparin sodium preparations. This is the reason we decided to launch the Project there. This move is also in line with our growth strategy of expanding the production line of heparin sodium preparations. The Project, once completed and operational, is expected to increase our production capability of heparin sodium preparations to 10 tons within three years.”

公司董事长兼首席执行官辛占昌先生表示:“我们很高兴能与CJT在这个项目上合作。作为全国生猪养殖和猪肉生产的重点地区,重庆肝素钠制剂生产原料充足。这就是我们决定在那里启动项目的原因。此举也符合我们扩大肝素钠制剂生产线的增长战略。该项目一旦建成投产,有望在三年内将我们肝素钠制剂的生产能力提高到10吨。”

About Qilian International Holding Group Limited

关于祁连国际有限公司

Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China. It focuses on the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. The Company’s products are sold in more than 20 provinces in China. For more information, visit the company’s website at http://qilianinternational.com/.


祁连国际股份有限公司总部位于中国甘肃省,是一家中国医药化工产品制造商。公司主要从事甘草产品、土霉素产品、中药衍生物产品、肝素产品、香肠肠衣、生物有机肥等产品的开发、生产、销售。公司产品行销全国20多个省份。欲了解更多信息,请访问公司网站http://qilianinternational.com/


Forward-Looking Statements


前瞻性陈述


This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, financial needs and the successful construction of the pig by-product processing project facility. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the SEC.

本公告包含1995年《私人证券诉讼改革法》安全港条款含义范围内的前瞻性陈述。除历史事实陈述外的所有陈述本公告为前瞻性陈述。这些前瞻性陈述涉及已知和未知的风险和不确定因素,并基于当前对未来事件和财务趋势的预期和预测,公司认为影响其财务状况、经营成果、业务策略、财务需求及猪副产品加工项目设施的成功建设。投资者可以通过以下文字或短语来识别这些前瞻性陈述:如“可能”、“将”、“预期”、“预期”、“目标”、“估计”、“打算”、“计划”、“相信”、“潜在”、“继续”、“是/可能是”或其他类似的表达方式。本公司没有义务更新前瞻性陈述以反映以下情况发生的事件或情况,或预期的变化,但法律规定的除外。尽管本公司相信这些前瞻性陈述中所表达的预期是合理的,但它不能向您保证这种预期本公司提醒投资者,实际结果可能与预期结果有重大差异,并鼓励投资者重新考虑其他因素可能影响其未来在公司注册中的结果声明以及提交给美国证券交易委员会的其他文件中。

For more information, please contact:


欲了解更多信息,请联系:


Qilian International Holding Group Limited

Email:QLI@qlsyy.net  qlsyygs@163.com